195 related articles for article (PubMed ID: 34153032)
1. Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads.
Byrne CM; Johnston C; Orem J; Okuku F; Huang ML; Rahman H; Wald A; Corey L; Schiffer JT; Casper C; Coombs D; Gantt S
PLoS Comput Biol; 2021 Jun; 17(6):e1009072. PubMed ID: 34153032
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
[TBL] [Abstract][Full Text] [Related]
3. Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.
de França TR; de Albuquerque Tavares Carvalho A; Gomes VB; Gueiros LA; Porter SR; Leao JC
Clin Oral Investig; 2012 Apr; 16(2):659-64. PubMed ID: 22186943
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
[TBL] [Abstract][Full Text] [Related]
5. Oropharyngeal group A streptococcal colonization disrupts latent Epstein-Barr virus infection.
Ueda S; Uchiyama S; Azzi T; Gysin C; Berger C; Bernasconi M; Harabuchi Y; Zinkernagel AS; Nadal D
J Infect Dis; 2014 Jan; 209(2):255-64. PubMed ID: 23935199
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus (EBV) Genotypes Associated with the Immunopathological Profile of People Living with HIV-1: Immunological Aspects of Primary EBV Infection.
Pereira LMS; França EDS; Costa IB; Lima IT; Freire ABC; Ramos FLP; Monteiro TAF; Macedo O; Sousa RCM; Freitas FB; Brasil Costa I; Vallinoto ACR
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215762
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus in oral mucosa from human immunodeficiency virus positive patients.
Santos L; Azevedo K; Silva L; Oliveira L
Rev Assoc Med Bras (1992); 2014; 60(3):262-9. PubMed ID: 25004273
[TBL] [Abstract][Full Text] [Related]
8. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils.
Hudnall SD; Ge Y; Wei L; Yang NP; Wang HQ; Chen T
Mod Pathol; 2005 Apr; 18(4):519-27. PubMed ID: 15696119
[TBL] [Abstract][Full Text] [Related]
9. Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV
Hernández DM; Valderrama S; Gualtero S; Hernández C; López M; Herrera MV; Solano J; Fiorentino S; Quijano S
Front Immunol; 2018; 9():2291. PubMed ID: 30337929
[TBL] [Abstract][Full Text] [Related]
10. Detection of lymphocytes productively infected with Epstein-Barr virus in non-neoplastic tonsils.
Ikeda T; Kobayashi R; Horiuchi M; Nagata Y; Hasegawa M; Mizuno F; Hirai K
J Gen Virol; 2000 May; 81(Pt 5):1211-6. PubMed ID: 10769062
[TBL] [Abstract][Full Text] [Related]
11. Association between human papilloma virus/Epstein-Barr virus coinfection and oral carcinogenesis.
Jiang R; Ekshyyan O; Moore-Medlin T; Rong X; Nathan S; Gu X; Abreo F; Rosenthal EL; Shi M; Guidry JT; Scott RS; Hutt-Fletcher LM; Nathan CA
J Oral Pathol Med; 2015 Jan; 44(1):28-36. PubMed ID: 25040496
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study.
Yan Y; Ren Y; Chen R; Hu J; Ji Y; Yang J; Shen J; Hu L; Pei H; Wang J; Qiu Y; Lu H; Huang L
Virol Sin; 2018 Jun; 33(3):227-233. PubMed ID: 29654554
[TBL] [Abstract][Full Text] [Related]
13. Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals.
Huynh GT; Rong L
J Theor Biol; 2012 Oct; 310():105-14. PubMed ID: 22683365
[TBL] [Abstract][Full Text] [Related]
14. Early impairment of CD8+ T cells immune response against Epstein-Barr virus (EBV) antigens associated with high level of circulating mononuclear EBV DNA load in HIV infection.
Legoff J; Amiel C; Calisonni O; Fromentin D; Rajoely B; Abuaf N; Tartour E; Rozenbaum W; Bélec L; Nicolas JC
J Clin Immunol; 2004 Mar; 24(2):125-34. PubMed ID: 15024179
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
[TBL] [Abstract][Full Text] [Related]
16. Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.
Slyker JA; Casper C; Tapia K; Richardson B; Bunts L; Huang ML; Maleche-Obimbo E; Nduati R; John-Stewart G
J Infect Dis; 2013 Jun; 207(12):1798-806. PubMed ID: 23493724
[TBL] [Abstract][Full Text] [Related]
17. Subclinical Cytomegalovirus and Epstein-Barr Virus Shedding Is Associated with Increasing HIV DNA Molecular Diversity in Peripheral Blood during Suppressive Antiretroviral Therapy.
Chaillon A; Nakazawa M; Rawlings SA; Curtin G; Caballero G; Scott B; Anderson C; Gianella S
J Virol; 2020 Sep; 94(19):. PubMed ID: 32641485
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy.
Righetti E; Ballon G; Ometto L; Cattelan AM; Menin C; Zanchetta M; Chieco-Bianchi L; De Rossi A
AIDS; 2002 Jan; 16(1):63-73. PubMed ID: 11741164
[TBL] [Abstract][Full Text] [Related]
20. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
